High-Performance, Low-Cost Sensing
PercuSense is a development-stage company focused on minimally invasive medical devices that use physiological triggers to continuously monitor and proactively diagnose progression of diseases such as sepsis, cancer or diabetes, ultimately enabling more effective, smart therapy. Our products are based on a first-in-category, calibration-free electrochemical sensor that combines principles of glucose detection inspired by islet cell technology with a novel sensing electrode design that yields a low-profile implant and superior mechanical stability.
Design for low-cost manufacturing is central to the PercuSense sensor. A low capital expense manufacturing cell has been developed that relies on mature materials and process methodology derived from non-medical technology industries. The manufacturing approach is scalable, flexible, and capable of supporting a multi-generational product strategy with limited retooling.
Unique to the PercuSense approach is the ability to include multiple channels of sensor functionality within a single implant. Opportunities for multi-analyte metabolic monitoring have application in health and wellness, chronic disease management and acute illness management. These accessible, low-cost metabolic monitoring tools have the potential to drive the future of personalized and precision medicine.
If you would like to inquire about a partnership opportunity, open positions or learn more about PercuSense and our technology, please submit the form below.